Bid outcomes
Lost bids carry more value than won ones — they chase big and lose bigWhere they win
4 authorities · 4 statesTop buyer organisations
Operating states
Top competitors
In tenders they both bid · bar shows how the awards splitRecent tenders awarded to Grifols India
- E-215/MMGPA/ Essential Medicines (2025-26)Maharashtra Medical Goods Procurement Authority Mumbai · Maharashtra · 25 Jul 2026₹1.7 Cr
- Anti Hemophilic DrugsTamilnadu Medical Services Corporation · Tamil Nadu · 13 Jul 2026₹6
- Online Short Term Tender for the Rate Contract for the supply of Medicines to Various Hospitals of Government of Haryana for a Period of Two Years For Group AHaryana Board Corporation · Haryana · 12 Jan 2026₹1,740
- rate contract of Medicines and Drugs for supply to H.P. Government Health InstitutionsDepartment of Health and Family Welfare · Himachal Pradesh · 10 Jun 2025₹30.0 Cr
About Grifols India Healthcare Private Limited
Grifols India Healthcare Private Limited appears as a bidder on 13 government tenders on record, from 11 buyer authorities in 10 states. Of its 12 decided bids, it was awarded 4 — a 33.3% win rate — worth ₹31.7 Cr in total. Its most recent award on record is from 30 Sept 2026.
Its largest buyer by awarded value is Department of Health and Family Welfare, at 94.7% of what it has won, out of 4 authorities that have awarded it work. Most of its awards come from Himachal Pradesh, Maharashtra and Haryana. On priced bids, its median quote is the lowest (L1).
It most often bids against Novo Nordisk India Private Limited, Reliance Life Sciences Pvt. Ltd and CIPLA LTD. Novo Nordisk India Private Limited bid on 9 of the same tenders and won 7 of them; Grifols India Healthcare Private Limited won 2.